Pharmacokinetic studies in rats demonstrated an oral bioavailability of 38.4%, with a mean Cmax of 2,252 ng/mL and terminal elimination half-lives of 3.80 1.10 hours (IV) and 6.90 1.20 hours (oral) (Awosemo et al., 2021)
Research indicates that methylcobalamin can modulate melatonin secretion, enhance light-sensitivity, and normalize circadian rhythm (your bodys 24-hour clock)
Studies indicate that BPC-157 may influence the dopaminergic and GABAergic systems, with researchers observing modulated behavior patterns in animal models
To determine if AOD 9604 is the right treatment for you, a trained clinician can go through your health history, explain how the therapy works, and help you determine if this treatment aligns with your wellness goals
This prevents pituitary downregulation and maintains long-term responsiveness
This product is not intended to diagnose, treat, cure, or prevent any disease or medical condition